Clinical Report: The Development of Paradoxical Psoriasis During TNF-α Inhibition
Overview
This report discusses the emergence of paradoxical psoriasis-like lesions in patients undergoing TNF-α antagonist therapy. The source material indicates that these skin manifestations may represent generalized abscessing staphyloderma.
Background
Paradoxical psoriasis is a recognized adverse effect of TNF-α antagonists, which are crucial for managing various chronic inflammatory diseases. The incidence of paradoxical psoriasis can reach up to 10%.
Data Highlights
No numerical data or trial data provided in the source material.
Key Findings
['Paradoxical psoriasis can manifest as various skin lesions, including pustular and eczematous types.', 'Six patients initially diagnosed with paradoxical psoriasis were found to have infections caused by Staphylococcus aureus.', 'These infections were likely due to impaired antimicrobial immunity from TNF-α blockade.', 'Topical antimicrobial therapy and systemic antibiotics led to resolution of the skin lesions.', 'The diagnosis of paradoxical psoriasis should be critically re-evaluated to consider the possibility of generalized abscessing staphyloderma.']
Clinical Implications
Healthcare providers should assess skin lesions in patients receiving TNF-α antagonists, as they may not always represent paradoxical psoriasis.
Conclusion
Many cases diagnosed as paradoxical psoriasis may represent generalized abscessing staphyloderma.
